Arrow Capital Pty Ltd acquired a new position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 10,000 shares of the technology company’s stock, valued at approximately $2,102,000. Veeva Systems accounts for approximately 1.9% of Arrow Capital Pty Ltd’s holdings, making the stock its 27th largest position.
Several other institutional investors and hedge funds also recently modified their holdings of VEEV. Norges Bank purchased a new position in Veeva Systems in the 4th quarter valued at about $294,785,000. Principal Financial Group Inc. increased its holdings in Veeva Systems by 138.9% during the 3rd quarter. Principal Financial Group Inc. now owns 2,179,284 shares of the technology company’s stock worth $457,366,000 after purchasing an additional 1,267,061 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Veeva Systems by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,558,592 shares of the technology company’s stock worth $536,972,000 after purchasing an additional 1,081,501 shares during the last quarter. Wealthfront Advisers LLC raised its position in shares of Veeva Systems by 29,760.5% in the 4th quarter. Wealthfront Advisers LLC now owns 1,048,700 shares of the technology company’s stock valued at $220,489,000 after purchasing an additional 1,045,188 shares in the last quarter. Finally, Marshall Wace LLP boosted its stake in shares of Veeva Systems by 413.3% during the 4th quarter. Marshall Wace LLP now owns 638,380 shares of the technology company’s stock valued at $134,219,000 after buying an additional 514,004 shares during the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Performance
Veeva Systems stock opened at $221.01 on Thursday. Veeva Systems Inc. has a 1 year low of $170.25 and a 1 year high of $258.93. The firm’s 50 day moving average price is $228.12 and its two-hundred day moving average price is $223.25. The firm has a market cap of $35.96 billion, a price-to-earnings ratio of 54.57, a price-to-earnings-growth ratio of 1.89 and a beta of 1.05.
Insider Buying and Selling
Wall Street Analyst Weigh In
A number of analysts recently issued reports on VEEV shares. KeyCorp dropped their price target on shares of Veeva Systems from $260.00 to $250.00 and set an “overweight” rating for the company in a research note on Wednesday. Robert W. Baird increased their target price on Veeva Systems from $283.00 to $285.00 and gave the stock an “outperform” rating in a report on Thursday, March 6th. StockNews.com raised shares of Veeva Systems from a “hold” rating to a “buy” rating in a report on Monday, February 17th. Stephens restated an “overweight” rating and issued a $280.00 price target on shares of Veeva Systems in a research report on Thursday, March 6th. Finally, The Goldman Sachs Group downgraded shares of Veeva Systems from a “buy” rating to a “sell” rating and lowered their price objective for the company from $261.00 to $200.00 in a research report on Thursday, January 23rd. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Veeva Systems currently has an average rating of “Moderate Buy” and an average price target of $256.32.
Get Our Latest Stock Analysis on Veeva Systems
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
See Also
- Five stocks we like better than Veeva Systems
- Consumer Discretionary Stocks Explained
- United Airlines Is in Reversal—If the Economy Doesn’t Stall
- How to Most Effectively Use the MarketBeat Earnings Screener
- Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility
- Best Stocks Under $10.00
- Spotify Stock Climbs as Its Growth Strategy Diversifies
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.